← FDA Drug Approvals (Drugs@FDA)

SERPASIL-APRESOLINE

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1954-04-01

Drug application

FDA Application #

NDA009296

Application type

New Drug Application

Brand name

SERPASIL-APRESOLINE

Generic name

Hydralazine Hydrochloride

Active ingredients

HYDRALAZINE HYDROCHLORIDE; RESERPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1954-04-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown